Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Anagenics ( (AU:AN1) ) is now available.
Anagenics Limited has reported that all resolutions put to shareholders at its 29 January 2026 General Meeting were approved by the required majority, including the ratification and approval of the issue of placement shares to sophisticated investors and the issuance of options to AFSL holders who assisted with the capital raising. The successful passage of these resolutions confirms shareholder support for the company’s recent capital-raising initiatives, providing Anagenics with additional financial flexibility to pursue growth in its beauty, health and wellness portfolio and potentially strengthening its position in the competitive global anti-aging solutions market.
More about Anagenics
Anagenics Limited (ASX: AN1) is a beauty, health and wellness company focused on the global distribution and sale of proprietary and licensed, clinically validated anti-aging solutions. Through its wholly owned subsidiary BLC Cosmetics, the group distributes leading Australian and international cosmetic and wellness brands, targeting consumers seeking differentiated, science-backed anti-aging products.
Current Market Cap: A$3.42M
Find detailed analytics on AN1 stock on TipRanks’ Stock Analysis page.